Tender Title: Interferon Beta 1a 30MCG Per 0.5ML Injection

Reference Number: GEM/2025/B/6173816
Issuing Authority: Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives

This tender invites bids for the supply of Interferon Beta 1a 30MCG Per 0.5ML Injection. The primary objective is to procure and deliver a total of 12 units of the specified medication to ensure the ongoing treatment and management of medical conditions as necessitated by the Ministry of Defence. The supplier shall guarantee that the medication meets stringent quality assurance and efficacy standards, complying with all relevant regulations defined by health authorities.

Eligibility Criteria

To be considered eligible for this tender, bidders must be a registered entity in accordance with applicable regulations. Preferred qualifications include a demonstrated history of supplying pharmaceuticals and compliance with health and safety protocols.

Technical Requirements

Bidders are required to submit detailed specifications that confirm that their product meets or exceeds the following:

• Quality certifications from recognized health authorities.
• Adherence to established manufacturing practices for pharmaceutical products.
• Documentation proving efficacy and safety of the drug.

Financial Requirements

Interested bidders must present financial stability through relevant certificates. This includes demonstrating their capacity to fulfill the order financially while ensuring competitive pricing is maintained. A bid price should be inclusive of all costs associated with delivery and any applicable taxes.

Document Submission Details

All required documentation must be submitted electronically through the specified government procurement platform. Proposals need to be well-structured, and bidders must ensure that all certificates and technical specifications are included to avoid disqualification.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and offers special considerations for startups. Suppliers from these categories are encouraged to bid, promoting a balanced competitive environment. They may benefit from reduced compliance burdens and prioritization in the evaluation process under specific local content and procurement rules.

Evaluation Process

Bids will be evaluated based on criteria that emphasize quality, compliance with technical specifications, and overall financial competitiveness. Only compliant bids that fulfill all eligibility requirements will advance to the next stage of selection. The evaluation committee will perform a thorough review of all submitted documents.

Delivery Locations

Successful suppliers will be responsible for delivering the Interferon Beta 1a medication to designated facilities as specified by the Department of Military Affairs. Specific addresses will be provided upon contract finalization.

Contact Information

For inquiries regarding this tender, interested parties are encouraged to review the official procurement platform for direct contacts related to the Department of Military Affairs.

This tender represents an essential procurement initiative by the Ministry of Defence to source vital medical supplies efficiently and effectively. Bidders are urged to ensure that all submitted proposals align with the outlined requirements to facilitate a smooth evaluation process.